Top Technology Stories


Comment & Analysis »

GBI Research

CRISPR: are genetic mutants the future of disease treatment?

The CRISPR-cas9 system is an up-and-coming biological technique with the potential to revolutionise the medical...

CRISPR: are genetic mutants the future of disease treatment?

Pharma Technology Focus – Issue 50

Pharma Technology Focus – Issue 50
 

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial
 

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

Company Releases »

Injectable and HPLE Carbohydrates for Protein Stabilisation and Optimisation

Pfanstiehl
Injectable and HPLE Carbohydrates for Protein Stabilisation and Optimisation

Determining Characterisations of Biopharmaceutical Stability with DSC

Malvern Instruments
Determining Characterisations of Biopharmaceutical Stability with DSC

ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

SYSTAG Systems Technik ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

Benefits of Trehalose

Pfanstiehl
Benefits of Trehalose

Gamlen Study: Breaking Anisotropic Rod-Shaped Particles

Gamlen Instruments Gamlen Study: Breaking Anisotropic Rod-Shaped Particles

Technology Insights »

Companies »